Anixa Biosciences secured a USPTO patent allowance for its ovarian cancer vaccine, strengthening its IP position and advancing its clinical development.

On top of providing comfort, they also help raise awareness for autism. Every Friday, a pianist greets the patients at the Richard M. Schulze Family Foundation Outpatient Center with his music. Milosz ...

In treating hematologic malignancies, engineered T-cell therapy outperforms standard transplantation with respect to chronic ...

A team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive immune checkpoint inhibitor treatments for colorectal cancer in the U.S.

Data evaluating safety and early signals of efficacy including updated local PFS from the completed dose escalation part of a Phase 1 study of ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who ...

An evidence-based AI platform aims to transform cancer care by providing comprehensive solutions for oncology patient ...

Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen ...

A digital health company aims to provide timely and personalized treatment plans for every person with cancer, as well as ...

From AI-focused collaborations to joint ventures in the fight against childhood cancer, here are 10 oncology partnerships ...